
Välj din etikett
visas direkt på vialenLabbrapport
PDF- Testad
- Tirzepatide Oral 500mcg × 25 Tabs
- Labb
- Analiza Białek
- Datum
- October 2026
- Resultat
- 568.25 mcg per tablet (500 mcg label)
- Beställningsnr.
- Lösenord
Oberoende testad, kan verifieras med lösenordet direkt hos labbet.
Tirzepatide Oral
GLP-1 Oral
- Labbtestad
- Skickas från Tyskland
Beställning
- DHL med spårning
- Diskret förpackning
4.6 av 5 på Trustpilot73 omdömen
Söks även som: Tirzepatid Oral · Tirzepatid Tabletten
I korthet
Tirzepatide Oral i siffror
Nyckeltalen från vårt lexikon. Dra punkten längs kurvan för att se hur mycket som finns kvar efter en dos, beräknat.
Hela lexikonartikelnHow long does it stay in the body?
Share left after one dose, calculated with a half-life of ~5 days
Simplified model without an absorption phase, half-life from the TPD lexicon.
Half-life
~5days
molecule, still taken daily
- Class
- Dual GIP / GLP-1 agonistoral
- Use
- Once daily in the morningfasted, with a little water
- Form
- Tablet500mcg, 25 per pack
- Sizes
- 500mcg/25tabs1 size in the shop
What studies show
All 5 sources in the lexicon- up to20.9 %New England Journal of Medicine, 2022
- Molecular Metabolism, 2018
- 0.8 %Clinical Pharmacokinetics, 2021
Kunskap
Allt om Tirzepatide Oral
Detaljerad information kommer snart.
Is tirzepatide approved as a tablet?
No. The compound is approved only as an injection, since 2022 according to ChEMBL. ClinicalTrials.gov lists no trial of oral tirzepatide, as of 26 October 2026.
How much of a tablet reaches the blood?
For tirzepatide this has not been measured in humans. For oral semaglutide, the only approved GLP-1 peptide to swallow, it is about 0.8 percent. Absorption varies by 137 percent from day to day and evens out to about 33 percent with daily intake.
Is there research on a tirzepatide tablet?
Yes, but only preclinical. A 2026 study developed a tablet with sodium caprate as an absorption enhancer. In a cell model permeability improved, in rats and beagle dogs blood levels were measurable.
Why does fasting matter so much?
With oral semaglutide absorption depended mainly on the fasting time after the tablet and on the water volume. Waiting longer raised it, more water lowered it. Absorption takes place directly in the stomach close to the tablet.
What do the trials on the compound itself show?
With the weekly injection weight fell by 15.0 to 20.9 percent after 72 weeks in SURMOUNT-1, by 3.1 percent on placebo. These figures apply to the injection and cannot be transferred to the tablet.
Which side effects are described?
For the compound mainly gastrointestinal effects such as nausea, vomiting, diarrhoea and reduced appetite, depending on the dose. In SURMOUNT-1 4.3 to 7.1 percent stopped because of side effects, 2.6 percent on placebo. There are no human data for the tablet itself.
Relaterat
Relaterade produkter
Tirzepatide Oral